You just read:

Versartis Announces Three Year Somavaratan Data at ENDO 2017 Showing Safety and Efficacy in Line with Historical U.S. Daily rhGH Data in Pediatric GHD

News provided by

Versartis, Inc.

03 Apr, 2017, 11:20 ET